DUE DILIGENCE

Business Development
Due Diligence
Venture Capital

Need
• Venture Capital company evaluating whether to participate in first round financing for new biopharmaceutical company

Approach
• Met and assessed management of NewCo – ex-pharmaceutical executives
• Reviewed intellectual property portfolio
• Assessed product and technology portfolio
• Assisted NewCo in licensing lead products to large pharmaceutical company for co-development support
• Recommended venture capital investment

Benefits
• NewCo grew to billion dollar market capitalization with exponential return on investment

COPYRIGHT 2006 - BioVerum Partners